Literature DB >> 20008652

Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome.

Carol F Lippa1, Andrea L Rosso, Lauren D Stutzbach, Manuela Neumann, Virginia M-Y Lee, John Q Trojanowski.   

Abstract

OBJECTIVE: To assess the transactive response DNA-binding protein 43 (TDP-43) burden in familial forms of Alzheimer disease (FAD) and Down syndrome (DS) to determine whether TDP-43 inclusions are also present.
DESIGN: Using standard immunohistochemical techniques, we examined brain tissue samples from 42 subjects with FAD and 14 with DS.
RESULTS: We found pathological TDP-43 aggregates in 14.0% of participants (6 of 42 and 2 of 14 participants with FAD and DS, respectively). In both FAD and DS, TDP-43 immunoreactivity did not colocalize with neurofibrillary tangles. Occasionally participants with FAD or DS had TDP-43-positive neuropil threads or dots. Overall, the amygdala was most commonly affected, followed by the hippocampus, with no TDP-43 pathology in neocortical regions. A similar distribution of TDP-43 inclusions is seen in sporadic Alzheimer disease, but it differs from that seen in amyotrophic lateral sclerosis and frontotemporal dementia.
CONCLUSIONS: Transactive response DNA-binding protein 43 pathology occurs in FAD and DS, similar to that observed in sporadic Alzheimer disease. Thus, pathological TDP-43 may contribute the cognitive impairments in familial and sporadic forms of Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008652      PMCID: PMC2864642          DOI: 10.1001/archneurol.2009.277

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  20 in total

1.  Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Lionel M Igaz; Linda K Kwong; Yan Xu; Adam C Truax; Kunihiro Uryu; Manuela Neumann; Christopher M Clark; Lauren B Elman; Bruce L Miller; Murray Grossman; Leo F McCluskey; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

2.  Structural diversity and functional implications of the eukaryotic TDP gene family.

Authors:  Hurng-Yi Wang; I-Fan Wang; Jayaramakrishnan Bose; C-K James Shen
Journal:  Genomics       Date:  2004-01       Impact factor: 5.736

3.  Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.

Authors:  Kunihiro Uryu; Hanae Nakashima-Yasuda; Mark S Forman; Linda K Kwong; Christopher M Clark; Murray Grossman; Bruce L Miller; Hans A Kretzschmar; Virginia M-Y Lee; John Q Trojanowski; Manuela Neumann
Journal:  J Neuropathol Exp Neurol       Date:  2008-06       Impact factor: 3.685

4.  Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.

Authors:  Tetsuaki Arai; Ian R A Mackenzie; Masato Hasegawa; Takashi Nonoka; Kazhuhiro Niizato; Kuniaki Tsuchiya; Shuji Iritani; Mitsumoto Onaya; Haruhiko Akiyama
Journal:  Acta Neuropathol       Date:  2009-01-13       Impact factor: 17.088

5.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

6.  Clinical and pathological continuum of multisystem TDP-43 proteinopathies.

Authors:  Felix Geser; Maria Martinez-Lage; John Robinson; Kunihiro Uryu; Manuela Neumann; Nicholas J Brandmeir; Sharon X Xie; Linda K Kwong; Lauren Elman; Leo McCluskey; Chris M Clark; Joe Malunda; Bruce L Miller; Earl A Zimmerman; Jiang Qian; Vivianna Van Deerlin; Murray Grossman; Virginia M-Y Lee; John Q Trojanowski
Journal:  Arch Neurol       Date:  2009-02

7.  Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies.

Authors:  Manuela Neumann; Linda K Kwong; Edward B Lee; Elisabeth Kremmer; Andrew Flatley; Yan Xu; Mark S Forman; Dirk Troost; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Acta Neuropathol       Date:  2009-01-06       Impact factor: 17.088

8.  Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations.

Authors:  Ian R A Mackenzie; Manuela Neumann; Eileen H Bigio; Nigel J Cairns; Irina Alafuzoff; Jillian Kril; Gabor G Kovacs; Bernardino Ghetti; Glenda Halliday; Ida E Holm; Paul G Ince; Wouter Kamphorst; Tamas Revesz; Annemieke J M Rozemuller; Samir Kumar-Singh; Haruhiko Akiyama; Atik Baborie; Salvatore Spina; Dennis W Dickson; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2008-11-18       Impact factor: 17.088

9.  Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease.

Authors:  Troy T Rohn
Journal:  Brain Res       Date:  2008-07-02       Impact factor: 3.252

10.  Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons.

Authors:  Peter T Nelson; Erin L Abner; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Charles D Smith; Daron G Davis; John W Poduska; Ela Patel; Marta S Mendiondo; William R Markesbery
Journal:  Brain Pathol       Date:  2008-11-19       Impact factor: 6.508

View more
  34 in total

Review 1.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

2.  Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration.

Authors:  Corey T McMillan; Jon B Toledo; Brian B Avants; Philip A Cook; Elisabeth M Wood; Eunran Suh; David J Irwin; John Powers; Christopher Olm; Lauren Elman; Leo McCluskey; Gerard D Schellenberg; Virginia M-Y Lee; John Q Trojanowski; Vivianna M Van Deerlin; Murray Grossman
Journal:  Neurobiol Aging       Date:  2013-12-02       Impact factor: 4.673

3.  White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration.

Authors:  Corey T McMillan; David J Irwin; Brian B Avants; John Powers; Philip A Cook; Jon B Toledo; Elisabeth McCarty Wood; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Murray Grossman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-09       Impact factor: 10.154

Review 4.  The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.

Authors:  Peter T Nelson; Erin L Abner; Ela Patel; Sonya Anderson; Donna M Wilcock; Richard J Kryscio; Linda J Van Eldik; Gregory A Jicha; Zsombor Gal; Ruth S Nelson; Bela G Nelson; Jozsef Gal; Md Tofial Azam; David W Fardo; Matthew D Cykowski
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

Review 5.  mRNP assembly, axonal transport, and local translation in neurodegenerative diseases.

Authors:  Bilal Khalil; Dmytro Morderer; Phillip L Price; Feilin Liu; Wilfried Rossoll
Journal:  Brain Res       Date:  2018-02-17       Impact factor: 3.252

6.  Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease.

Authors:  Cyntia Tremblay; Isabelle St-Amour; Julie Schneider; David A Bennett; Frédéric Calon
Journal:  J Neuropathol Exp Neurol       Date:  2011-09       Impact factor: 3.685

7.  TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.

Authors:  Alice S Chen-Plotkin; Travis L Unger; Michael D Gallagher; Emily Bill; Linda K Kwong; Laura Volpicelli-Daley; Johanna I Busch; Sebastian Akle; Murray Grossman; Vivianna Van Deerlin; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

8.  Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.

Authors:  Susana Boluda; Michiyo Iba; Bin Zhang; Kevin M Raible; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-12-24       Impact factor: 17.088

9.  Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.

Authors:  Pilar M Ferraro; Charles Jester; Christopher A Olm; Katerina Placek; Federica Agosta; Lauren Elman; Leo McCluskey; David J Irwin; John A Detre; Massimo Filippi; Murray Grossman; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

10.  TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study.

Authors:  Margaret E Flanagan; Brenna Cholerton; Caitlin S Latimer; Laura S Hemmy; Steven D Edland; Kathleen S Montine; Lon R White; Thomas J Montine
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.